Shares of biotech firm MannKind Corporation (MNKD) fell today after the US Food and Drug Administration failed to approve its next-generation insulin ...
MannKind Corporation (MNKD) CEO and Chairman Alfred Mann has picked up 700000 more shares of his biotech company's stock, at a price of $8.71, ...
MannKind Corporation (NASDAQ:MNKD) percentage change fell -10.89%, currently trading at $8.76 and its overall traded volume is 2.61M shares while reporting ...
Currently, the company has a market capital of approximately 6.80B. (NASDAQ:MNKD) MannKind Corp. belonging to the Healthcare sector and Biotechnology ...